Table 1.
Structure | Constraint type | Vol (%) | Dose (Gy) | Priority |
---|---|---|---|---|
GTV | Superior | 0 | PD + 8 | 150 |
Inferior | 98 | PD | 200 | |
C1 | Superior | 0 | PD + 8 | 150 |
Inferior | 98 | PD + 2 | 200 | |
C2 | Superior | 0 | PD + 8 | 150 |
Inferior | 98 | PD + 4 | 200 | |
C3 | Superior | 0 | PD + 8 | 150 |
Inferior | 98 | PD + 6 | 200 | |
GTV–C1 | Superior | 0 | PD + 3 | 100 |
C1–C2 | Superior | 0 | PD + 5 | 100 |
C2–C3 | Superior | 0 | PD + 7 | 100 |
Normal tissue | Superior | RefDA10 | 10 | 300 |
Superior | RefDA12 | 12 | 300 |
PD — the prescribed dose, taken from the dynamic conformal arcs (DA) plan of this case, similarly the V10 (RefDA10) and V12 (RefDA12) values for normal tissue; GTV — gross tumour volume